The Leadership Behind Celljevity’s Breakthrough Innovations
The remarkable success of Celljevity in revolutionizing regenerative medicine stems directly from its extraordinary leadership team. At the helm is Diederik van der Reijt, Chairman and CEO, whose unique background bridges finance, entrepreneurship, and biotechnology innovation.
Van der Reijt’s journey to Celljevity began with founding successful enterprises including a high-frequency trading firm, followed by strategic investments in biotech ventures. His experience building NKore Biotherapeutics provided valuable insights into cellular therapy development and commercialization. This diverse background brings a distinct perspective to Celljevity – combining business acumen with a humanitarian vision for accessible healthcare.
The scientific direction of Celljevity comes from Dr. Yi Eve Sun, whose pioneering work in cellular reprogramming is world-renowned. As a former Deputy Director of UCLA’s Stem Cell Biology department with over 100 publications in prestigious journals like Cell, Nature, and Science, Dr. Sun brings unparalleled expertise to Celljevity’s research endeavors. Her ability to bridge Eastern and Western scientific approaches has been instrumental in developing the company’s groundbreaking therapies.
Celljevity’s leadership team is further strengthened by Chief Commercial Officer Georg Nebgen, who brings extensive experience in healthcare venture capital and strategic growth. The addition of Nobel Laureate Dr. Thomas Südhof as a scientific advisor provides additional scientific credibility and neurobiological expertise.
This leadership combination – entrepreneurial vision, scientific brilliance, commercial strategy, and Nobel-caliber advisory – creates a uniquely powerful foundation for innovation. Together, they’ve developed not only revolutionary technologies but also an unprecedented commitment to global healthcare equity.
By uniting diverse expertise under a shared mission of transformative, accessible healthcare, Celljevity’s leadership team exemplifies the interdisciplinary collaboration required to truly revolutionize medicine in the 21st century.